Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.from IndiaTV India: Google News Feed https://ift.tt/32xqn7T
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.